Quick Links

Author: Tina Taylor

This study is testing an investigational drug called frexalimab in adolescents and adults age 12-35 years old with newly diagnosed type 1 diabetes who are on insulin therapy (adults age 18-35 will be enrolled first, followed by 12 to 21-year-olds later in the study). You will...

TrialNet is testing rituximab-pvvr and abatacept, one after the other, to learn if using both treatments extend insulin production in people (ages 8-45) who were newly diagnosed with type 1 diabetes (T1D). Each therapy has a history of safety and effectiveness. Rituximab-pvvr is FDA-approved to...

We are conducting this study to collect a wide variety of neuroimaging data and questionnaire data. Researchers at the UW and beyond will use these data to explore how your experiences and background are related to brain structure and activity. Participant Eligibility Inclusion Criteria: - You are aged 18-30. - No...

The purpose of the CUB Study is to improve our understanding of brain development in infants whose mothers used cannabis during pregnancy and in those whose mothers did not. Although cannabis use has increased among pregnant and non-pregnant people nationwide, there is still limited and...

We are a group of researchers conducting a study to develop an interface that can help clinicians and patients assess one's hand function. Regular tools do not show small changes in hand and arm movements very well, and they are laborious and time-consuming. Our study...

The purpose of this study is to determine if a 4 week self-management intervention after a person receives an implantable cardioverter defibrillator (ICD) shock, will prevent the development of post-traumatic stress disorder (PTSD). Participant Eligibility Must have: 1) ICD implant 2) received at least 1 ICD shock in week...

SITE PARTNERS
uw-footer